0001192482-15-000200.txt : 20150513
0001192482-15-000200.hdr.sgml : 20150513
20150513163703
ACCESSION NUMBER: 0001192482-15-000200
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150512
FILED AS OF DATE: 20150513
DATE AS OF CHANGE: 20150513
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC
CENTRAL INDEX KEY: 0001267565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 780 DEDHAM STREET, SUITE 800
CITY: CANTON
STATE: MA
ZIP: 02021
BUSINESS PHONE: 781-713-3699
MAIL ADDRESS:
STREET 1: 780 DEDHAM STREET, SUITE 800
CITY: CANTON
STATE: MA
ZIP: 02021
FORMER COMPANY:
FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC
DATE OF NAME CHANGE: 20031020
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hirsch David
CENTRAL INDEX KEY: 0001619884
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37372
FILM NUMBER: 15858911
MAIL ADDRESS:
STREET 1: C/O LONGITUDE CAPITAL PARTNERS, LLC
STREET 2: 800 EL CAMINO REAL, SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-05-12
0001267565
COLLEGIUM PHARMACEUTICAL, INC
COLL
0001619884
Hirsch David
C/O LONGITUDE CAPITAL PARTNERS, LLC
800 EL CAMINO REAL, SUITE 220
MENLO PARK
CA
94024
1
0
1
0
Common Stock
2015-05-12
4
C
0
1860570
A
1860750
I
By Longitude Venture Partners, L.P.
Common Stock
2015-05-12
4
C
0
458102
A
2318672
I
By Longitude Venture Partners, L.P.
Common Stock
2015-05-12
4
C
0
741830
A
3060502
I
By Longitude Venture Partners, L.P.
Common Stock
2015-05-12
4
P
0
196070
12.00
A
3256572
I
By Longitude Venture Partners, L.P.
Common Stock
2015-05-12
4
C
0
37290
A
37290
I
By Longitude Capital Associates, L.P.
Common Stock
2015-05-12
4
C
0
9182
A
46472
I
By Longitude Capital Associates, L.P.
Common Stock
2015-05-12
4
C
0
14868
A
61340
I
By Longitude Capital Associates, L.P.
Common Stock
2015-05-12
4
P
0
3930
12.00
A
65270
I
By Longitude Capital Associates, L.P.
Series B Convertible Stock
2015-05-12
4
C
0
12837935
0
D
Common Stock
1860570
0
I
By Longitude Venture Partners, L.P.
Series B Convertible Stock
2015-05-12
4
C
0
257303
0
D
Common Stock
37290
0
I
By Longitude Capital Associates, L.P.
Series C Convertible Stock
2015-05-12
4
C
0
3160905
0
D
Common Stock
458102
0
I
By Longitude Venture Partners, L.P.
Series C Convertible Stock
2015-05-12
4
C
0
63356
0
D
Common Stock
9182
0
I
By Longitude Capital Associates, L.P.
Series D Convertible Stock
2015-05-12
4
C
0
5045381
0
D
Common Stock
741830
0
I
By Longitude Venture Partners, L.P.
Series D Convertible Stock
2015-05-12
4
C
0
101128
0
D
Common Stock
14868
0
I
By Longitude Capital Associates, L.P.
All series of Convertible Preferred Stock automatically converted into Collegium Pharmaceutical, Inc. common stock on a 1-for-6.9 basis immediately prior to the closing of the initial public offering and had no expiration date.
Reflects the conversion of preferred stock into Collegium Pharmaceutical, Inc. common stock on a 1-for-6.9 basis which became effective on May 12, 2015.
The shares are held by Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. (collectively, the "Longitude Funds"). Longitude Capital Partners, LLC is the general partner of the Longitude Funds. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of Longitude Capital Partners, LLC and in their capacity as such, may be deemed to exercise shared voting and investment power over the shares held by the reporting persons. David Hirsch is a member of Longitude Capital Partners, LLC. Dr. Hirsch disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
/s/ Paul Brannelly as Attorney-In-Fact For David Hirsch
2015-05-13